Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 8 | 2023 | 107 | 5.540 |
Why?
|
| Artificial Intelligence | 8 | 2023 | 238 | 4.270 |
Why?
|
| Intestinal Volvulus | 7 | 2024 | 36 | 2.360 |
Why?
|
| Digestive System Abnormalities | 7 | 2024 | 32 | 2.220 |
Why?
|
| Ultrasonography | 11 | 2024 | 940 | 2.210 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2023 | 2054 | 1.780 |
Why?
|
| Radiology Information Systems | 3 | 2024 | 23 | 1.660 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 97 | 1.650 |
Why?
|
| Radiologists | 7 | 2022 | 44 | 1.620 |
Why?
|
| Foreign Bodies | 3 | 2021 | 104 | 1.390 |
Why?
|
| Child | 36 | 2024 | 24222 | 1.160 |
Why?
|
| Pediatrics | 4 | 2024 | 1141 | 0.960 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 270 | 0.930 |
Why?
|
| Appendicitis | 2 | 2024 | 128 | 0.890 |
Why?
|
| Intussusception | 2 | 2022 | 46 | 0.890 |
Why?
|
| Pandemics | 5 | 2022 | 1100 | 0.890 |
Why?
|
| Workflow | 2 | 2021 | 114 | 0.880 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1590 | 0.880 |
Why?
|
| Device Approval | 1 | 2023 | 13 | 0.870 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 21 | 0.860 |
Why?
|
| Radiation Protection | 1 | 2023 | 54 | 0.850 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 23 | 0.850 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 265 | 0.800 |
Why?
|
| Radiography | 7 | 2023 | 822 | 0.790 |
Why?
|
| Thyroid Nodule | 1 | 2021 | 20 | 0.740 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.730 |
Why?
|
| Duodenum | 1 | 2021 | 97 | 0.730 |
Why?
|
| Outpatients | 1 | 2023 | 253 | 0.730 |
Why?
|
| Burnout, Professional | 1 | 2023 | 114 | 0.720 |
Why?
|
| Teleradiology | 1 | 2020 | 5 | 0.710 |
Why?
|
| Humans | 47 | 2024 | 123033 | 0.710 |
Why?
|
| Fractures, Bone | 1 | 2022 | 186 | 0.710 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 12 | 0.700 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 7 | 0.700 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 220 | 0.680 |
Why?
|
| Hospitals, Community | 1 | 2020 | 55 | 0.680 |
Why?
|
| Child Health Services | 1 | 2020 | 86 | 0.650 |
Why?
|
| Shift Work Schedule | 1 | 2019 | 19 | 0.650 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 197 | 0.630 |
Why?
|
| Hospitals, Pediatric | 2 | 2022 | 779 | 0.620 |
Why?
|
| Play and Playthings | 1 | 2018 | 18 | 0.610 |
Why?
|
| Digestive System | 1 | 2018 | 59 | 0.610 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 207 | 0.570 |
Why?
|
| Referral and Consultation | 1 | 2021 | 529 | 0.560 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 712 | 0.520 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 216 | 0.500 |
Why?
|
| Societies, Medical | 3 | 2024 | 676 | 0.470 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 3546 | 0.450 |
Why?
|
| Radiation Dosage | 4 | 2023 | 134 | 0.430 |
Why?
|
| Retrospective Studies | 13 | 2024 | 16028 | 0.420 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 2015 | 0.420 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 288 | 0.410 |
Why?
|
| Clinical Competence | 1 | 2019 | 973 | 0.400 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 28 | 0.370 |
Why?
|
| Laryngitis | 1 | 2009 | 6 | 0.340 |
Why?
|
| Tracheitis | 1 | 2009 | 14 | 0.340 |
Why?
|
| Croup | 1 | 2009 | 13 | 0.330 |
Why?
|
| Bronchitis | 1 | 2009 | 34 | 0.330 |
Why?
|
| Hospitals | 2 | 2023 | 396 | 0.330 |
Why?
|
| Infant | 12 | 2024 | 12346 | 0.320 |
Why?
|
| Child, Preschool | 11 | 2024 | 13882 | 0.300 |
Why?
|
| Lymphoma | 1 | 2011 | 321 | 0.300 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 3664 | 0.290 |
Why?
|
| Heart Injuries | 1 | 2007 | 46 | 0.280 |
Why?
|
| Thoracic Injuries | 1 | 2007 | 91 | 0.280 |
Why?
|
| Angiography | 1 | 2007 | 215 | 0.270 |
Why?
|
| Hematoma | 1 | 2007 | 93 | 0.270 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 209 | 0.250 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2826 | 0.240 |
Why?
|
| Adolescent | 10 | 2023 | 19103 | 0.220 |
Why?
|
| Aorta | 1 | 2007 | 542 | 0.220 |
Why?
|
| Adult | 5 | 2023 | 29013 | 0.220 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8105 | 0.220 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 48 | 0.210 |
Why?
|
| Vascular Malformations | 1 | 2024 | 81 | 0.210 |
Why?
|
| Esophagus | 2 | 2021 | 213 | 0.210 |
Why?
|
| Urography | 2 | 2013 | 31 | 0.200 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 31 | 0.200 |
Why?
|
| Ileal Diseases | 1 | 2022 | 21 | 0.190 |
Why?
|
| Contrast Media | 2 | 2021 | 470 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 235 | 0.180 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 50 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2011 | 135 | 0.170 |
Why?
|
| Triage | 1 | 2021 | 140 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 500 | 0.170 |
Why?
|
| Observer Variation | 1 | 2021 | 296 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 146 | 0.170 |
Why?
|
| Intestines | 1 | 2024 | 570 | 0.170 |
Why?
|
| Eye | 1 | 2021 | 227 | 0.160 |
Why?
|
| United States | 4 | 2024 | 10639 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 169 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 159 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1877 | 0.150 |
Why?
|
| Patient Safety | 1 | 2022 | 394 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 1255 | 0.140 |
Why?
|
| Male | 13 | 2024 | 60066 | 0.140 |
Why?
|
| Female | 12 | 2024 | 65497 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 243 | 0.130 |
Why?
|
| Algorithms | 1 | 2023 | 1592 | 0.130 |
Why?
|
| Software | 1 | 2021 | 676 | 0.130 |
Why?
|
| Young Adult | 4 | 2022 | 8850 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 592 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.120 |
Why?
|
| Urination | 1 | 2013 | 21 | 0.110 |
Why?
|
| Radiometry | 1 | 2013 | 38 | 0.110 |
Why?
|
| Urethra | 1 | 2013 | 83 | 0.110 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2013 | 80 | 0.100 |
Why?
|
| Texas | 1 | 2020 | 3560 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3240 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2011 | 91 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 2964 | 0.090 |
Why?
|
| Urologic Diseases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 155 | 0.090 |
Why?
|
| Documentation | 1 | 2011 | 120 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 1213 | 0.070 |
Why?
|
| Aortography | 1 | 2007 | 200 | 0.070 |
Why?
|
| Craniotomy | 1 | 2006 | 108 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 175 | 0.060 |
Why?
|
| Hypotension | 1 | 2006 | 177 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2024 | 32 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 58 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 205 | 0.050 |
Why?
|
| Hemangioma | 1 | 2024 | 95 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2024 | 130 | 0.050 |
Why?
|
| Enema | 1 | 2022 | 37 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5045 | 0.050 |
Why?
|
| Bronchi | 1 | 2021 | 98 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2006 | 762 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 622 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 164 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 54 | 0.040 |
Why?
|
| Body Composition | 1 | 2022 | 513 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2021 | 332 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1284 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3315 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12118 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6368 | 0.030 |
Why?
|
| Risk Factors | 2 | 2007 | 10006 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 1541 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 937 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Washington | 1 | 2013 | 33 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3367 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 228 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 153 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 6217 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6026 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 586 | 0.020 |
Why?
|
| Aged | 1 | 2007 | 19082 | 0.020 |
Why?
|
| Middle Aged | 1 | 2007 | 25980 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1001 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2006 | 23 | 0.020 |
Why?
|
| Isoflurane | 1 | 2006 | 45 | 0.020 |
Why?
|
| Fentanyl | 1 | 2006 | 47 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2006 | 111 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 2799 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2758 | 0.010 |
Why?
|